EBITDA grew by 23% in the second half of the year,bringing full-year EBITDA to US$1.1billion at a margin of 10%.

REYKJAVIK,Iceland,Feb. 24,2025-- 3Z Pharmaceuticals,aCNS-focused therapeutic development specialist,today announced the publication of a groundbreaking study in The Journal of Pharmacology and Experim

PARIS,Feb. 25,2025-- Little Artists Art Studio,is proud to share the historic debut of their young and rising talents at the prestigious Art Capital Paris: Le Salon des Artistes Français at the

TAIPEI,Feb. 25,2025-- The Asian Hardware Online Exhibition 2025 (AsianHardware 2025) is set to redefine the hardware products industry with its innovative hybrid format,seamlessly blending virtual and

Another Step Forward in Global Expansion HONG KONG,Feb. 25,2025-- As global capital reassesses the investment value of innovative Chinese companies,the development of innovative vaccines in China is i

SHANGHAI,Feb. 25,2025-- YolTech Therapeutics,a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines,today reported positive results fr